Deposition of IgM anti-oxLDL occurs in mouse and human atherosclerotic lesions [163], and administration or overexpression of anti-oxLDL antibodies reduced inflammation, lesion area and progression of atherosclerosis [108]. Here, CD40LG is linked to atherosclerosis.